SCHEMBL17433499

SCHEMBL17433499

O=C(O)c1ccc(CC2=CC=CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 3/20 0.49
▸ ALDH1A1 P00352 3/20 0.48
▸ TSHR P16473 2/20 0.47
▸ RXRA P19793 2/20 0.44
▸ RXRB P28702 1/20 0.44
▸ RXRG P48443 1/20 0.44
▸ KMT2A Q03164 5/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ NR4A1 P22736 1/20 0.41
▸ APEX1 P27695 1/20 0.41
▸ APOBEC3A P31941 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11554501 0.83 ALDH1A1 (0.32) ALDH1A1TSHRKMT2ATDP1
SCHEMBL2836936 0.77 CALM1 (0.46) ALDH1A1TSHRLMNATP53KDM4E
SCHEMBL9144956 0.76 CALM1 (0.44) TSHRLMNATP53KDM4EMAPT
SCHEMBL9143779 0.76 CALM1 (0.44) TSHRLMNATP53KDM4EMAPT
SCHEMBL68390 0.74 SRD5A2 (0.69) SRD5A2ALDH1A1TSHRRXRARXRB
Hydrochloric Acid SCHEMBL25188150 0.72 SRD5A2 (0.67) SRD5A2ALDH1A1TSHRRXRARXRB
Hydrochloric Acid SCHEMBL7133360 0.72 SRD5A2 (0.67) SRD5A2ALDH1A1TSHRRXRARXRB
SCHEMBL12814968 0.71 MGAM (0.31) GAA
SCHEMBL23522757 0.70 ALDH1A1 (0.39) ALDH1A1TSHR
SCHEMBL11104544 0.70 ALDH1A1 (0.87) SRD5A2ALDH1A1TSHRRXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9399077-B2 Metallocene compounds and labeled molecules comprising the same for in vivo imaging APTENIA S.R.L. (IT) 2016-07-26 — — US disclosed
US-20160008495-A1 Metallocene Compounds and Labeled Molecules Comprising the Same for In Vivo Imaging APTENIA S.R.L. (IT) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160008495-A1 Metallocene Compounds and Labeled Molecules Comprising the Same for In Vivo Imaging MEN1, MPI, TFRC SRD5A2 3636/4885ALDH1A1 3718/4885TSHR 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback